Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Stein

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Diabetes Care|June 1, 1991
Drug treatment of hypertension in patients with diabetes mellitusP P Stein, H R Black
Postgraduate Medicine|October 26, 1999
The many 'faces' of Graves' disease. Part 1. Eyes, pulse, skin, and neck provide important clues to diagnosisM W Felz, P P Stein
JAMA|February 12, 1992
Morning distort: we are not amusedR M McLean, P P Stein
Medicine|January 1, 1991
A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experienceP P Stein, H R Black
Postgraduate Medicine|November 24, 1999
The many 'faces' of Graves' disease. Part 2. Practical diagnostic testing and management optionsM W Felz, P P Stein
The Medical Clinics of North America|July 1, 1993
The role of diet in the genesis and treatment of hypertensionP P Stein, H R Black
Metabolism: Clinical and Experimental|October 1, 1991
The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker ratsL Bowen, P P Stein, R Stevenson, et al.
Clinical Pharmacology and Therapeutics|March 30, 2007
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptinG A Herman, P P Stein, N A Thornberry, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 6, 2007
Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary careM N Cook, C J Girman, P P Stein, et al.
Diabetes, Obesity & Metabolism|February 16, 2007
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trialM A Nauck, G Meininger, D Sheng, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Diabetes Care|June 1, 1991
Drug treatment of hypertension in patients with diabetes mellitusP P Stein, H R Black
Postgraduate Medicine|October 26, 1999
The many 'faces' of Graves' disease. Part 1. Eyes, pulse, skin, and neck provide important clues to diagnosisM W Felz, P P Stein
JAMA|February 12, 1992
Morning distort: we are not amusedR M McLean, P P Stein
Medicine|January 1, 1991
A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experienceP P Stein, H R Black
Postgraduate Medicine|November 24, 1999
The many 'faces' of Graves' disease. Part 2. Practical diagnostic testing and management optionsM W Felz, P P Stein
The Medical Clinics of North America|July 1, 1993
The role of diet in the genesis and treatment of hypertensionP P Stein, H R Black
Metabolism: Clinical and Experimental|October 1, 1991
The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker ratsL Bowen, P P Stein, R Stevenson, et al.
Clinical Pharmacology and Therapeutics|March 30, 2007
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptinG A Herman, P P Stein, N A Thornberry, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 6, 2007
Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary careM N Cook, C J Girman, P P Stein, et al.
Diabetes, Obesity & Metabolism|February 16, 2007
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trialM A Nauck, G Meininger, D Sheng, et al.
Pageof 2